Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

STATEN ISLAND, N.Y. — Richmond University Medical Center’s Bariatric and Metabolic Institute has earned the title of “Blue ...

A new study has made the case for synching your daily calories with your own circadian rhythm to improve glucose metabolism, ...

Bariatric surgery is a medical procedure that alters the digestive system to help individuals with obesity lose weight by ...

Soda, fruit punches, sports drinks, and even many packaged juices are among the worst offenders when it comes to added sugar. A single can of soda can contain more than 35 grams of sugar—well above a ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...

In patients with metabolic-associated steatotic liver disease or metabolic-associated steatohepatitis, resmetirom and ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...